These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 16093977

  • 1. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE.
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Tabatabaei S, Harisinghani M, McDougal WS.
    J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
    [Abstract] [Full Text] [Related]

  • 4. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA, Saokar A, Harisinghani MG.
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM, Group.
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [Abstract] [Full Text] [Related]

  • 6. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Kroon BK, Horenblas S.
    J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
    [No Abstract] [Full Text] [Related]

  • 7. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R.
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [Abstract] [Full Text] [Related]

  • 8. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R, Chan P, Czarnota G, Haider MA, Jhaveri K, Jewett M, Fyles A, Jaffray D, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):844-51. PubMed ID: 19095369
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr 01; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
    Narayanan P, Iyngkaran T, Sohaib SA, Reznek RH, Rockall AG.
    Radiographics; 2009 Apr 01; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
    [Abstract] [Full Text] [Related]

  • 14. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
    Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.
    Clin Imaging; 2009 Apr 01; 33(4):301-5. PubMed ID: 19559353
    [Abstract] [Full Text] [Related]

  • 15. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.
    Saokar A, Braschi M, Harisinghani M.
    Abdom Imaging; 2006 Apr 01; 31(6):660-7. PubMed ID: 16680506
    [Abstract] [Full Text] [Related]

  • 16. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC, Keller TM, Fröhlich JM, Fink D, Caduff R, Seifert B, Marincek B, Kubik-Huch RA.
    Radiology; 2002 Nov 01; 225(2):527-36. PubMed ID: 12409591
    [Abstract] [Full Text] [Related]

  • 17. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
    Nguyen BC, Stanford W, Thompson BH, Rossi NP, Kernstine KH, Kern JA, Robinson RA, Amorosa JK, Mammone JF, Outwater EK.
    J Magn Reson Imaging; 1999 Sep 01; 10(3):468-73. PubMed ID: 10508310
    [Abstract] [Full Text] [Related]

  • 18. MR imaging staging of pelvic lymph nodes.
    Kim JY, Harisinghani MG.
    Magn Reson Imaging Clin N Am; 2004 Aug 01; 12(3):581-6. PubMed ID: 15271372
    [Abstract] [Full Text] [Related]

  • 19. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
    Harisinghani MG, Dixon WT, Saksena MA, Brachtel E, Blezek DJ, Dhawale PJ, Torabi M, Hahn PF.
    Radiographics; 2004 Aug 01; 24(3):867-78. PubMed ID: 15143236
    [Abstract] [Full Text] [Related]

  • 20. Nanoparticles in rectal cancer imaging.
    Koh DM, Brown G, Collins DJ.
    Cancer Biomark; 2009 Aug 01; 5(2):89-98. PubMed ID: 19414926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.